Rekombinanter ErbB2/Her2 (Pertuzumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter ErbB2/Her2 (Pertuzumab Biosimilar) Antikörper (ABIN7200658)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Pertuzumab Biosimilar, Human HER2 Monoclonal Antibody
-
Spezifität
- The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu.
-
Produktmerkmale
- Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
-
Aufreinigung
- Protein A or G affinity column
-
Reinheit
- >95 % by reducing SDS-PAGE
-
Sterilität
- 0.2 μm filtered
-
Endotoxin-Niveau
- < 1 EU per 1 mg of the protein by the LAL method
-
Immunogen
- The monoclonal antibody pertuzumab biosimilar was produced in the pertuzumab biosimilar CHO stable cell line.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by pertuzumab.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- > 3 mg/mL
-
Buffer
- PBS, pH 7.4, no stabilizers or preservatives.
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4°C,-20 °C
-
Informationen zur Lagerung
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
-
Haltbarkeit
- 12 months
-
-
- ErbB2/Her2 (Pertuzumab Biosimilar)
-
Andere Bezeichnung
- Pertuzumab Biosimilar
-
Substanzklasse
- Biosimilar
Target
-